BIOS | · 9 min read By: Alix Ventures — Supporting Early Stage Life Science Startups Driving Patient Impact Intro It’s no secret that the traditional drug discovery model is expensive, time-consuming, and has recently produced compounds with marginal efficacy in clinical trials and high failure rates. Large biopharma companies are increasingly outsourcing R&D to academic labs and small/mid-size startups via licensing partnerships […]
A.I.
How Elon Musk’s Neuralink Could Reshape Entire Economies
How Elon Musk’s Neuralink Could Reshape Entire Economies
“Tech Giants Are Paying Huge Salaries for Scarce A.I. Talent” – (NY Times)
Our two cents: We (Starbridge Partners) are also seeing a rising salaries as larger Fortune 500 companies figure out how they will apply Data Science / A.I. to their business and competition for experienced PhD level specialist, data scientists heats up further. There is a reasonable pool of good candidates at the recent Masters / […]